| __timestamp | Jazz Pharmaceuticals plc | Viatris Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 406114000 | 1499100000 |
| Thursday, January 1, 2015 | 449119000 | 1923500000 |
| Friday, January 1, 2016 | 502892000 | 2351400000 |
| Sunday, January 1, 2017 | 544156000 | 2564000000 |
| Monday, January 1, 2018 | 683530000 | 2397300000 |
| Tuesday, January 1, 2019 | 736942000 | 2503400000 |
| Wednesday, January 1, 2020 | 854233000 | 3344600000 |
| Friday, January 1, 2021 | 1451683000 | 4529200000 |
| Saturday, January 1, 2022 | 1416967000 | 4179100000 |
| Sunday, January 1, 2023 | 1343105000 | 4650100000 |
Unveiling the hidden dimensions of data
In the competitive landscape of pharmaceuticals, operational efficiency is key. Over the past decade, Viatris Inc. and Jazz Pharmaceuticals plc have showcased contrasting trends in their Selling, General, and Administrative (SG&A) expenses. From 2014 to 2023, Viatris Inc. consistently reported higher SG&A costs, peaking at approximately $4.65 billion in 2023, a staggering 210% increase from 2014. In contrast, Jazz Pharmaceuticals saw a more moderate rise, with expenses growing by about 230% over the same period, reaching around $1.34 billion in 2023. This divergence highlights Viatris's expansive operational scale compared to Jazz's more streamlined approach. As the pharmaceutical industry evolves, understanding these financial dynamics offers valuable insights into each company's strategic priorities and market positioning.
Breaking Down SG&A Expenses: Zoetis Inc. vs Viatris Inc.
Cost of Revenue: Key Insights for Viatris Inc. and Jazz Pharmaceuticals plc
SG&A Efficiency Analysis: Comparing Viatris Inc. and BioMarin Pharmaceutical Inc.
Selling, General, and Administrative Costs: Viatris Inc. vs Ultragenyx Pharmaceutical Inc.
Operational Costs Compared: SG&A Analysis of Viatris Inc. and Corcept Therapeutics Incorporated
Cost Management Insights: SG&A Expenses for Viatris Inc. and BioCryst Pharmaceuticals, Inc.
Comparing SG&A Expenses: Bio-Techne Corporation vs Jazz Pharmaceuticals plc Trends and Insights
Cost Management Insights: SG&A Expenses for Jazz Pharmaceuticals plc and Soleno Therapeutics, Inc.
Comparing SG&A Expenses: Jazz Pharmaceuticals plc vs Bausch Health Companies Inc. Trends and Insights
Jazz Pharmaceuticals plc and Ligand Pharmaceuticals Incorporated: SG&A Spending Patterns Compared
SG&A Efficiency Analysis: Comparing Jazz Pharmaceuticals plc and Amphastar Pharmaceuticals, Inc.
Jazz Pharmaceuticals plc vs MiMedx Group, Inc.: SG&A Expense Trends